Anika Therapeutics Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Anika Therapeutics stock has a consensus rating of "Buy" and an average price target of $17.5. The average 1-year stock price forecast is 21.02% higher than the current stock price, while the lowest is $17 (+17.57%) and the highest is $18 (+24.48%).

Price Target: $17.5 (+21.02%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$17.5	$17.5	$18
Change	+17.57%	+21.02%	+21.02%	+24.48%

* Price targets were last updated on Apr 30, 2026.

Analyst Ratings

The average analyst rating for Anika Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Sep '25	Nov '25	Jan '26	Feb '26	Apr '26
Strong Buy	2	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington	Barrington	Buy Maintains $17	Buy	Maintains	$17	+17.57%	Apr 30, 2026
Anderson Schock B. Riley Securities	B. Riley Securities	Buy Maintains $16 → $18	Buy	Maintains	$16 → $18	+24.48%	Feb 27, 2026

Financial Forecast

Revenue This Year

118.61M

from 112.82M

5.14%

from 112.82M

Revenue Next Year

126.58M

from 118.61M

6.72%

from 118.61M

EPS This Year

0.41

from 0.11

272.73%

from 0.11

EPS Next Year

0.46

from 0.41

12.20%

from 0.41

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	147.79M	113.83M	120.79M	119.91M	112.82M	118.61M
Revenue Growth	13.29%	-22.98%	6.12%	-0.73%	-5.91%	5.14%
Gross Profit	89.41M	73.22M	82.53M	76.60M	63.81M	69.98M
Gross Margin	60.50%	64.33%	68.33%	63.89%	56.56%	59.00%
Operating Income	-12.02M	3.67M	844.00K	-4.50M	-11.05M	-12.16M
Net Income	4.13M	-14.86M	-82.67M	-56.39M	-10.88M	-9.90M
EPS	-	-	-	-	0.11	0.41
EPS Growth	-	-	-	-	-31.25%	272.73%
Forward PE	-	-	-	39.19	53.39	35.27
Free Cash Flow	10.35M	2.59M	6.19M	35.40M	13.28M	-4.03M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	118.7M
Avg	118.6M
Low	118.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.2%
Avg	5.1%
Low	5.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.41
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	272.7%
Low	-